S
ocial marketing began as a discipline in the 1970s, when Philip Kotler and Gerald Zaltman argued that the same marketing strategies that have been so successful in selling products and services to consumers could also be used to promote socially beneficial ideas, attitudes, and behaviors. 1 Kotler and Andreasen 2 describe social marketing as ''differing from other areas of marketing only with respect to the objectives of the marketer and his or her organization. Social marketing seeks to influence social behaviors not to benefit the marketer, but to benefit the target audience and the general society. '' In the context of health, social marketing attempts to increase healthy behaviors in a population by using proven marketing techniques used to promote commercial products. Andreasen 3 refers to health behaviors in defining social marketing as ''the application of proven concepts and techniques drawn from the commercial sector to promote changes in diverse socially important behaviors such as drug use, smoking, sexual behavior. . .. This marketing approach has an immense potential to affect major social problems if we can only learn how to harness its power.'' By ''proven techniques,'' Andreasen was referring to lessons drawn from behavioral theory, social and cognitive psychology, 4 and marketing science regarding health behavior, human reaction to messages and message delivery, and the marketing mix or the ''4 Ps'' of marketing (i.e., place, price, product, and promotion). 5 The relevance of these principles to social marketing in health care practice is illustrated by their use in pharmaceutical marketing (e.g., promotion of off-label use of medications) aimed at practitioners and consumers. 6 
REVIEW OF LITERATURE AND METHODS IN SOCIAL MARKETING
The health care delivery system is undergoing significant changes as a result of several recent trends, including an emphasis on evidence-based medicine, 7 advances in medical science and technology, and public health needs of an aging population with increased prevalence of chronic conditions. 8 Together, these forces have led the Institute of Medicine (IOM) to recommend that the health care system be ''reinvented'' with the goal of fostering innovation and improving health care delivery.
One of the key goals of the IOM's action plan is to create a system that is ''patient centered,'' meaning ''providing care that is respectful of, and responsive to, individual patient preferences, needs, and values, and ensuring that patient values guide all clinical decisions. '' 8ðp3Þ This goal aligns well with the new consumerism or activism on the part of patients who are interested in being more involved in their health and health care. 7 The social marketing concept of consumer orientation and application of key principles from the field of health communication could be used to help create a health care system that promotes patient centeredness. 9 When applying principles of social marketing to health care, researchers should consider several nuances and challenges. First, medical knowledge is asymmetric in that health care providers generally have more knowledge and patients have less; therefore, patients rely on the providers to assist them with medical decision making. However, communication channels have changed dramatically in recent years, increasing patients' direct access to more medical information. Doctors' role in healing has changed as they are no longer the exclusive source of medical knowledge, largely as a result of the Internet. 10 Second, and also related to technological advancements, social marketers are now faced with challenges such as increases in the number and type of health issues competing for the public's attention, significant limitations on people's time, and an increase in the number and type of communication channels.
11 New media and new technologies such as handheld devices create an environment in which consumers and health care providers can receive health messages-and messages that may encourage unhealthy behavior-at any time and in any place. 12 Choosing the right context, channels, and messages that will motivate people to pay attention and use the health information are among the greatest health communication and social marketing challenges.
Third, the existence of health insurance, particularly comprehensive ''first-dollar coverage,'' removes or limits the direct financial burden on health care consumers. Consumers are able to purchase a product-a medical procedure costing thousands of dollars-for a small portion of the cost if it is covered by their insurance. Therefore, their focus is more on the benefit they will receive from the product and possible physical and psychosocial ''costs'' associated with it, as opposed to financial costs. This unique facet of health care products should be taken into consideration when conveying information to consumers.
Researchers can use the social marketing wheel to address some of these challenges when applying social marketing to health care products. The basic elements or stages of social marketing can be summarized in Figure 1 , which is excerpted from the US National Cancer Institute's (NCI's) influential ''Pink Book'' for health communication planning. 13 There are 6 basic stages: planning and strategy development using behavioral theory; selecting communication channels and materials based on behavior change objectives and knowledge of the target audience (e.g., using extant data on consumer health status or behavior); development and pretesting of materials, typically using qualitative methods (e.g., focus group testing of potential health messages); implementing the communication program or ''campaign'' (e.g., a mass media campaign or a planned program of one-on-one communication about preventive behavior by a health care practitioner); assessing effectiveness in terms of audience exposure, awareness, reactions to messages, and behavioral outcomes (e.g., evaluation research on the extent of improved diet or continued nonsmoking status); and refining the materials for future communications. The stages constitute a circular process in which the last stage feeds back into the first to create a continuous loop of planning, implementation, and improvement.
Concepts underlying the wheel offer opportunities and potential challenges to health care practitioners and consumers. For example, health care providers have substantial information about their patients (target audience knowledge), have the ability to deliver messages such as improved diet or smoking cessation that are specific to patients' needs (implementation), and can assess outcomes of message delivery in subsequent visits (assessing effectiveness). Moreover, these steps can be followed in concert with existing population-level social marketing campaigns, such as the opportunity to counsel preteens to increase physical activity, which was afforded to pediatricians by the heightened awareness and interest in physical activity created by the Centers for Disease Control and Prevention's VERB: It's What You Do campaign. 14 Commercial health marketing campaigns, such as Merck's human papilloma virus (HPV) campaign aimed at teenage girls, offer additional opportunities for reinforcement of highly visible health promoting advertising.
Audience Segmentation
One of the key decisions in social marketing that guides most health communication planning is whether to deliver messages to a general audience or to ''segment'' into target audiences. Audience segmentation is generally based on sociodemographic, cultural, and behavioral characteristics that may be associated with intended behavior change. For example, the NCI's ''5-a-Day for Better Health'' campaign developed specific messages aimed at Hispanic consumers, recognizing that national data suggest they consume fewer fruits and vegetables than other groups and may have cultural norms about cooking and nutrition that tend to discourage consuming locally available produce. 13 The broadest approach to audience segmentation includes both group-targeted messages and ''personalized'' messages. In targeted communications, messages are prepared using information about population groups. For example, commercial marketers aim messages at specific customer profiles (e.g., upper middle-income women with children living in suburban locations). This combination of techniques has been effectively used to develop socially desirable images and prevention messages, such as appealing images aimed at youth who are ''open'' to initiating smoking used in the American Legacy Foundation's ''truth 1 '' tobacco countermarketing campaign. ''Personalized'' materials use a person's name to draw attention to a generic message (as used in marketing by mass mail).
Tailored Messages
A more specific, individualized form of segmentation is ''tailored'' communications. Tailored communications use individual-level data (e.g., about an individual's lifestyle, where they live, what they buy, health behaviors) to develop messages and materials aimed specifically at the individual and very similar others. This approach derives from commercial marketing practices using product purchase and other market research data that can specify likely consumer reaction to product or service promotions (e.g., as used in promotional mailings). Tailoring allows marketers to generate customized messages that are aligned with individuals' needs and interests.
Over the past 10 to 15 years, ''tailored health communications'' has emerged as a widely used approach to addressing public health issues. Kreuter and others 15 define tailored health communications as ''any combination of information and behavior change strategies intended to reach one specific person, based on characteristics that are unique to that person, related to the outcome of interest, and derived from an individual assessment.'' 15 Because they address very specific cognitive and behavioral patterns as well as individual demographic characteristics, tailored materials are more precise than targeted ones but are, by nature, more limited in population reach and more expensive to develop and implement.
By definition, tailored health communications are patient centered. They reflect the realities of people's everyday lives, current beliefs and attitudes, and lifestyles and preferences, 16 which is a primary reason why they have the potential to be more effective.
Evidence about the Efficacy of Social Marketing Using Mass Communications
There is substantial evidence that social marketing is effective in changing health behaviors on a population level. Evidence from mass communication indicates that social marketing has been effective in changing health behavior and behavioral mediators, though often with small effect sizes. 17 In a meta-analytic review of 48 US social marketing campaigns based on mass media, Snyder and Hamilton 18 found that the average campaign accounted for about 9% of the variation in health risk behavior outcomes but with heterogeneous results. The subset of ''noncoercive'' campaigns (i.e., those simply delivering health information, as opposed to campaigns that attempted to persuade and advocate a behavior) accounted for about 5% of observed variation (i.e., 5% of total variation in the subset, as compared with 9% for all 48 campaigns reviewed).
A review of 17 recent European media campaigns on a range of topics, including promotion of HIV testing, myocardial infarction admissions, immunizations, and cancer screenings, found similar small but positive effects. 19 Like previous research, this study shows that single or occasional behaviors can be easier to promote than behavior requiring repetition and maintenance over time. 20 Some behaviors such as breastfeeding and vitamin A promotion and the switch to 1% milk have shown greater effect sizes than those observed on average for social marketing campaigns.
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Branded Health Messages as an Application of Social Marketing
Public health branding is the application of commercial branding strategies to promote health behavior change. 22 Such brands use well-known techniques such as modeling socially desirable behaviors (i.e., being socially accepted by not smoking) and imagery (e.g., being hip or cool by exercising) to encourage emulation of healthy behaviors.
One area in which branding appears to be growing-and offers potential for brief clinician counseling-is nutrition and communication of nutrition behavior. 23 On the basis of that workshop, Snyder 24 examined health communication campaigns and provided insights to help inform nutrition campaigns specifically in the future. She noted that nutrition campaigns tend to be more successful than other public health topics, such as youth drug abuse prevention. Because a number of effective branded nutrition campaigns (e.g., ''5-a-Day for Better Health'') are widely known to the public, nutrition counseling may be an opportunity for clinicians to raise the salience and acceptance of campaign messages through brief counseling during patient visits.
Counterdetailing and Prescriber Behavior
Efforts to influence physician prescription practice are a form of social marketing that has had mixed success. In their review of 51 published articles from 1988 through 1997, Figueiras and others 25 found that even among the 8 studies with a high quality of evidence, only 1 demonstrated positive results from active interventions (e.g., group education, individual outreach visits). Some authors 26, 27 suggest that the literature cited in this and other recent systematic reviews is plagued by the absence of common nomenclature, inadequate study designs, too short time horizons, and a focus on process rather than outcome. 28 Despite these limitations, they suggest 3 generalizations based on systematic reviews:
• Interventions that rely solely on passive information transfer are relatively ineffective. This includes disseminating articles and delivering traditional lectures in continuing medical education, as well as providing unsolicited information such as clinical guidelines, medication profiles, or drug use reviews.
• Active knowledge translation strategies, including audit and feedback involving comparison with peers and ''real-time'' reminders, are usually effective, but the effects are modest. Such approaches may not be cost-effective. Educational outreach or academic detailing is the most consistently effective intervention reported.
• Interventions that incorporate 2 or more distinct strategies (i.e., that are multifaceted) are more likely to work than single interventions. 28 Despite these cautionary articles, there are potential social marketing strategies to change prescribing behavior. Pharmaceutical companies have been extremely successful in their endeavors, using a variety of methods. When strong evidence is available, as in the recent series of studies on the limited effectiveness of postmenopausal hormone replacement therapy, physicians markedly decrease their prescription of that drug class. A recent Cochrane Review on the effect of educational outreach or academic detailing on professional practice and health care outcomes concluded that when outreach visits are combined with additional interventions, they appear to be effective. 29 In particular, there is evidence from 5 trials in different health care settings that using outreach visits in combination with a social marketing approach can be effective, especially when targeted at high prescribers.
30 Although in-person visits are effective, they are also quite expensive. Multiple interventions have been demonstrated to be effective, taking into account these evidence-based principles that do not involve in-office visits. 30 The use of multiple types of interventions seems to be very valuable. Some principles underlying effective pharmaceutical detailing are listed as follows:
• Defining specific problems and objectives Potentially significant barriers to changing prescribing behavior may occur at a variety of levels, including structural (e.g., financial disincentives), organizational (e.g., inappropriate skill mix, lack of facilities or equipment), peer group (e.g., local standards of care not in line with desired practice), individual (e.g., knowledge, skills, information overload within busy practices leading to acts of omission or error), and patient expectations (e.g., created by direct-to-consumer pharmaceutical advertising). 31 These barriers could potentially be overcome by employing active dissemination approaches such as those outlined above.
Applications in Health Care
There are a number of opportunities for social marketing to be used to change health care consumer behavior. Researchers such as those funded through Agency for Healthcare Research and Quality (AHRQ) evidence-based practice centers seek to synthesize, generate, and translate knowledge about health care provider and consumer behavior. Although this work is typically aimed at informing health care providers and consumers, rather than using persuasive social marketing strategies to change their behavior, this research substantially overlaps the target populations for many social marketing efforts, including older adults, pregnant women and young children, and people with disabilities. Thus, there may be opportunities to use social marketing strategies with these populations on health care topics. In the remainder of this article, we explore various methodologies, specific cases, and opportunities to translate social marketing evidence and principles for use in health care behavior change.
Challenges and Limitations
A number of challenges and potential limitations of social marketing in health care settings should be acknowledged. As noted above, message clutter is a major challenge to all social marketing. There are countless health messages delivered through commercial channels, such as pharmaceutical marketing and health plan advertising, as well as social marketing aimed at prevention and health promotion (e.g., in tobacco, nutrition and physical activity, and HIV/AIDS). Multiple converging messages can lead to information overload for patients that may be difficult for practitioners to alleviate through brief counseling. In health care settings, this manifests itself in terms of patients' ability to understand their options, behavioral choices, and implications of treatment decisions.
Another challenge is the complexity of, and decision making required by, some health information. The strongest evidence from social marketing discussed earlier comes from studies of conditions and behaviors for which there is solid clinical and basic scientific evidence that specific changes are beneficial. For example, the evidence for the health benefits of smoking prevention, increased fruit and vegetable consumption, or condom use is clear cut. In these cases, practitioners can add value to patient decision making by providing a trusted source of additional information that can motivate behavior change. 32 However, in cases where scientific information about health behavior is lacking or uncertain, what role should practitioners play? Many medical decisions are probabilistic (i.e., outcomes are not certain, and there are benefits and risks associated with prevention and treatment options) and thus require knowledge acquisition and informed decision making rather than behavior change in response to persuasive social marketing messages.
Several transferable principles from social marketing appear relevant to practitioner-patient communication in health care settings. These include the following: 1) countermarketing to counteract the effects of competing, less healthy messages; 2) the need to provide credible and likeable ''arguments'' for behavior change; 3) the use of theory-based behavior change models; 4) the use of social modeling and behavioral alternatives for audiences; and 5) risk communication in cases where the behavioral choices are clear. These principles have been used widely in recent public health communication 33À36 and have potential applications in health care. We explore those potential applications in the following case histories.
CASE HISTORIES
To illustrate different ways that social marketing has addressed the 5 transferable principles of messaging, communication, and dissemination outlined earlier, we describe 3 case studies of social marketing efforts: countermarketing in tobacco control, informed decision making (IDM), and the application of countermarketing and IDM to affect health care consumer behavior. These cases are intended to illustrate ways in which these principles have been successfully applied and suggest how they can be potentially used in health care, rather than providing definitive evidence of effectiveness and transferability.
Case 1: Tobacco Countermarketing
In this case study, we examine the use of targeted, oppositional social marketing to counteract the marketing of cigarettes. This approach can potentially be used by many other fields, including work to counteract pharmaceutical messaging that goes beyond previous counterdetailing efforts. In public health marketing, there is a primary distinction between oppositional and nonoppositional strategies. Nonoppositional strategies typically attempt to deliver health promotion and disease prevention messages by communicating harms (i.e., health risks) and benefits of specific behaviors such as smoking or the consumption of 5 servings of fruits and vegetables per day. 32 In contrast, oppositional strategies assume that the health message is in competition with an unhealthy message. Countermarketing is a strategy to deliver information to counter the effects of marketing by companies with competing interests (e.g., tobacco, pharmaceuticals). In tobacco control, countermarketing of tobacco industry messages has been widely used to promote populationlevel health behavior change, prevention of smoking initiation (primarily among youth), and promotion of smoking cessation. 37 The countermarketing strategy is firmly grounded in the social marketing wheel. 13 For example, the American Legacy Foundation ''truth 1 '' campaign was based in audience formative research with teens to identify attitudinal and behavioral factors that might promote them to reject tobacco use as a socially desirable behavior. 38 The campaign evaluation used both ongoing implementation tracking and a comprehensive national effectiveness evaluation. 37 ''Competition'' between health promotion and prevention messages, on one hand, and unhealthy product marketing messages, on the other, is a key premise underlying countermarketing. Countermarketers take away ''market share'' from unhealthy product marketing by providing more compelling facts, information, and imagery (rational and affective appeals) than the competition. 33 Competition between tobacco control countermarketing efforts and the tobacco industry has generally taken the form of competition between ''brands.'' In the case of Legacy's ''truth 1 '' and other state-funded media campaigns, such as Florida's ''TRUTH'' and Ohio's ''stand,'' countermarketers have explicitly branded antitobacco health messages to promote a nonsmoking lifestyle. 33;39 Branding in this case refers to the adoption and maintenance of alternative behaviors (nonsmoking) to the countermarketed behavior (smoking). Branded countermarketing campaigns use commercial marketing techniques to provide additional consumer value to encourage adoption and maintenance of the behaviors. As in the case of commercial products or services, persuasive imagery is used to market nonsmoking and to counter the imagery used by industry to sell smoking as socially desirable behavior. Thus, in tobacco control, countermarketers compete with tobacco industry marketing to take away ''market share'' by promoting adoption of alternative behaviors (e.g., nonsmoking as a way to be socially accepted) to increase nonsmoking behavioral choices among the overall market of potential smokers (those who have not initiated and current smokers who may quit).
Countermarketing in tobacco control offers strategies that could be disseminated as best practices to other areas of public health, such as health care and communication between practitioners and patients. In particular, social marketing campaigns in tobacco control demonstrate that delivering rational arguments (tobacco use risks and promotion of behavioral alternatives) using messages found to be credible and likeable by the target audience 4 can succeed in attaining a campaign's goals. In health care settings, countermarketing techniques could deliver credible science-based information to consumers to counter inaccurate messages or to promote informed decision making about health insurance options. Countermarketing could also be used against misleading marketing to practitioners and to reinforce other information sources such as continuing medical education, medical conferences, and publications.
Case 2: Informed Decision Making about Prostate Cancer Screening
In this case study, we discuss how principles of social marketing are critical in fostering effective communication with patients, particularly when the clinical evidence is uncertain and the message is complicated. Evidence-based medicine (EBM) has been defined as the ''conscientious, explicit, and judicious use of current best evidence in making decisions about care of individual patients.'' 40ðp71Þ Beach and colleagues 41 elaborate this definition by explaining that EBM combines a systematic review of existing clinical evidence with an individual physician's personal experience along with careful consideration of the patient's perspective and preferences. This is consistent with the patient centeredness movement in health care, which seeks to adapt care to individual patient needs and expectations. Welldesigned communication materials and decisionmaking tools can help to achieve the goals of EBM and patient centeredness by facilitating informed decision making based on the individual's situation.
Social marketers pay close attention to human reaction to messages and message delivery, making adjustments as needed to increase comprehension and potential impact. It is important to pretest messages with the target audience prior to use, especially when the message contents are complicated. Formative research techniques, including individual and group interviews, can help to ensure that the messages and materials are culturally sensitive and effectively use plain language.
Developing messages about prostate cancer screening can be very challenging, for example. Screening for prostate cancer using the prostate-specific antigen (PSA) test is contentious because of disagreement over the reliability and efficacy of the screening tests for prostate cancer, the potential harm associated with screening and treatment, and the uncertainty about whether the test is associated with a reduction in morbidity and death. Leading medical groups have different recommendations about prostate cancer screening. For example, the American Cancer Society recommends that asymptomatic men aged 50 and older who have a life expectancy of at least 10 years be offered the PSA test annually, whereas the American College of Preventive Medicine recommends against routine population screening. Using US Preventive Services Task Force methods, 42 researchers concluded that the evidence was insufficient to recommend either for or against routine screening for prostate cancer. 43 Thus, many medical organizations advocate for an informed decision-making process. 44 IDM occurs ''when an individual understands the nature of the disease or condition being addressed; understands the clinical service and its likely consequences, including risks, limitations, benefits, alternatives, and uncertainties; has considered his or her preferences as appropriate; has participated in decision making at a personally desirable level; and either makes a decision consistent with his or her preferences and values or elects to defer a decision to a later time.'' 45 This necessitates that an individual's preferences and values weigh heavily into the decision. 46 Those developing health communication messages about prostate cancer screening or other topics that lack clear evidence must first convince audience members that there are limits to medical science, which some laypeople find quite surprising. In these instances, the social marketing messages are to 1) consider your individual values and preferences, 2) talk to your doctor about them and your options, and 3) consider being more involved in the decision-making process because the individual must deal with the consequences of the decision. Despite scientific advancements and medical technologies, we envision that there will be an increasing number of complex health care issues to be conveyed, and social marketers will need to craft messages that not only educate consumers but also foster patient/provider communication.
Social marketing also emphasizes the importance of choosing the correct channel(s) to convey the message. Kotler and Roberto 47 discuss the tradeoffs of 3 major communication approaches-mass media, selective, and personal-acknowledging that many campaigns require all 3 given their mutual reinforcement. When the message is complicated, an interpersonal component may be necessary so that consumers can ask questions to clarify their understanding. In this case, there is some form of face-to-face communication that is helpful in addressing barriers and concerns, building trust, and gaining commitment. 48 This method can certainly be more costly but may be necessary.
Most IDM or shared decision-making interventions have been conducted in clinical settings. However, the community-based setting is a promising alternative or complement to that approach and is well suited for interpersonal communication. There is some early evidence that a multimodal, community-based IDM intervention may positively affect men's recognition that there is an actual decision to be made about screening, 49 their knowledge about prostate cancer, 50 and their preference for taking greater part in the decision-making process about screening. 49 In the future, we expect that social marketing principles will become increasingly useful, particularly when crafting messages that need to convey clinical information to a lay audience.
Providers need support so that they can deliver high-quality health care, particularly when medical uncertainty exists and effective patient/clinician communication is critical. In Crossing the Quality Chasm, the IOM 8 concluded that quality improvement cannot be achieved given the constraints of the current system and processes of care. Delivery system improvements are needed to raise awareness and interest, offer knowledge and tools, and facilitate the formation of networks to support organizational development around quality improvement. Specifically, providers need information, decision support tools, and training to effectively communicate with patients about complicated medical issues.
Case 3: Pharmaceutical Marketing of Gabapentin for Bipolar Disorder
In this case study, we explore the potential of oppositional social marketing as a strategy to counteract pharmaceutical messaging. This strategy offers an important opportunity for clinicians to engage in social marketing directly to patients and in support of potential future population-level social marketing campaigns for drug classes such as antiepileptic drugs (AEDs).
Certain AEDs (e.g., carbamazepine, valproate, lamotrigine) have been approved by the US Food and Drug Administration (FDA) for use in specific types of bipolar mood disorder (e.g., acute mania, mixed episodes, depression, hypomania). WarnerLambert, the manufacturer of gabapentin, an AED originally approved in 1993 by the FDA only for adjunctive treatment of partial complex seizures, promoted its off-label use for the treatment of psychiatric disorders, including bipolar disorder, although its efficacy for the indication had not been demonstrated. Steinman and others 6 recently outlined the tactics used in the industry promotion of gabapentin and documented its success in causing a remarkable increase in gabapentin use for psychiatric disorders, with more than 900,000 prescriptions registered in the first quarter of 2000. In fact, more than 90% of prescriptions for gabapentin were for off-label uses. 51 As discussed above, there is a substantial literature on counterdetailing as a method to promote evidencebased practice to clinicians. 30 More recently, countermarketing based on social marketing principles has begun to be used to reach practitioners, such as psychiatrists, to counter pharmaceutical industry marketing and misinformation. 52 This work is informed by countermarketing in tobacco control and also by the marketing practices of pharmaceuticals. Studying the marketing practices of large pharmaceutical firms can provide valuable lessons for developing competing messages delivered through direct-to-consumer advertising, provider-mediated communication (e.g., in the treatment session), and a variety of channels to reach providers themselves.
There appear to be significant opportunities to use the activities included in the social marketing wheel 13 and apply countermarketing to pharmaceutical messaging. For example, as in tobacco control, audience formative research could be conducted to understand perceptions of pharmaceutical products and marketing. Such research could identify attitudinal and behavioral factors (e.g., higher credibility of alternative message sources such as medical organizations) that could be used in countermarketing messaging and then reinforced by clinicians in brief counseling during patient visits.
Industry practices offer substantial material, providing guidance to developers of countermarketing strategies. Steinman and others 6 identified the concerted marketing strategies used by Warner-Lambert to promote the off-label use of gabapentin. Through document discovery in the settlement between Pfizer (formerly Warner-Lambert) and the National Association of Attorneys General (NAAG), this research provides insight into pharmaceutical industry marketing of gabapentin to psychiatrists and other health care providers. 6 Several features of this promotion are worth noting. First, it generally ignored the evidence base for appropriate prescription of gabapentin. 53 This put consumers at undue risk and is ethically highly questionable. In health care decision making, an important question becomes, ''How can social marketing counteract this through dissemination of evidence to prescribers and consumers?'' Specifically, Warner-Lambert used continuing medical education (CME) events at which speakers could communicate directly to physicians. They attended physician advisory boards and consultant meetings at these events and elsewhere to conduct informal exploratory and concept testing ''research'' on how best to promote gabapentin for off-label use. This approach involved having medical doctors and other health care professionals, serving as WarnerLambert consultants, meet with prescribers and promote the benefits of gabapentin in the treatment of mood disorders, which is not indicated by the existing evidence. 6 In addition, Warner-Lambert developed a research and publications strategy to reach prescribers in professional journals. Scientists, funded directly by the company as consultants, disseminated articles touting the benefits and efficacy of gabapentin as a promotional strategy, often beyond the scope of existing evidence or even counter to the evidence. 6 Although for very different purposes and with questionable ethical standards, the pharmaceutical industry has used many of the same marketing strategies proven effective in social marketing. This suggests that countermarketing could target both health care providers and consumers through competing strategies. For example, psychiatrists who prescribe mood disorder medications could be reached through dissemination of evidence-based drug information at CME events, other meetings and conferences, Internet-based resources, pocket cards, PDA applications, or similar forms of direct promotion. In addition, the evidence base on gabapentin and the AED drug class could be published in leading professional journals read by prescribers. 53 Clinicians and consumers likely will require different messages and channels. Evidence-based drug information, much of it highly technical, would be a critical element of any efforts to change prescriber behavior. Such a strategy would differ from traditional pharmaceutical marketing to clinicians in its purposes and outcomes (i.e., ensuring evidencebased prescription behavior rather than simply selling drugs). The channels through which such information would be communicated (e.g., journals, CME events) are specific to physicians. A strategy to change both prescriber and consumer behavior would need to involve integrated, complementary messages using audience-specific channels.
Consumers could be reached through public service announcements or paid direct-to-consumer advertising, over the Internet, and through physicianpatient interaction (mediated communication). The latter strategy would be particularly valuable as part of a systematic effort to reach prescribers, as described above, alongside a consumer education campaign.
DISCUSSION AND CONCLUSIONS
Four basic points emerge from this review. 1) Social marketing is an effective population-based behavior change strategy that has potential for greatly expanded application in health.
2) The social marketing wheel offers a set of unifying principles that apply across a wide range of cases and applications of social marketing, including health care and related contexts. 3) Social marketing in health care will span a range of situations in which evidence is more or less definitive, requiring the integration of EBM and IDM strategies. 4) The evidence base on the efficacy of the use of social marketing in health care is quite limited, much of it derived from earlier counterdetailing studies, and a new research agenda of efficacy and effectiveness messaging research is needed.
Social marketing is an effective behavior change approach that has been proven effective across a wide range of health promotion and disease prevention subject areas. In particular, reviews such as those by Snyder and Hamilton 18 and Hornik 21 show that targeted, persuasive messaging of some behaviors can promote adoption. Moreover, targeted social marketing (aimed at specific target audiences such as adolescents using specific promotional strategies such as branded messaging) has been highly effective in fields such as tobacco control. Studies such as the one by Evans and others 33 have shown that messages that provide appealing, healthy behavioral alternatives; give positive social models of healthy behavior; and use the audience's aspirations and ideals have been effective in preventing health risk behavior such as smoking. Underlying behavior change 54 and message reaction theory 4 suggest that these techniques are transferable to other topics and domains, such as health care. One conclusion of this review is that, due to the substantial overlap in a) subject matter and b) marketing and communication strategies, there are tremendous opportunities and need for the fields of social marketing and evidence-based medicine to work much more closely together. In particular, because there are relatively few examples of social marketing programs and interventions in health care, there is very little direct evidence of the transferability of communication strategies targeting providers or consumers. However, there is some indirect evidence available from the success of pharmaceutical marketing to practitioners and consumers.
To develop these strategies for practitioners, we need more experimental efficacy research (i.e., experiments in which messages are delivered and reactions measured under controlled conditions) to demonstrate how social marketing can best be used to change health care provider and consumer behavior. Effectiveness research on the implementation of social marketing in health care would naturally follow efficacy studies. Examples from health promotion and prevention suggest that this would entail evaluations of campaigns that use audience segmentation and targeted and, as feasible, tailored messaging aimed at specific audiences. This suggests an opportunity to build a research agenda on social marketing and health care consumer behavior, which would advance both fields.
A number of potentially effective targeted and tailored message strategies would naturally be the subject of the proposed research agenda, including the following:
• Target messages based on sociodemographic factors, cultural beliefs or values, psychosocial determinants, or geographic location • Personalize risk data-use stories, narratives, and anecdotes • Use graphics and other pictorial materials to clarify messages • Be sensitive to local norms, such as culture, speech, and dress • Use a variety of approaches such as written, oral, and electronic • Use clear, nontechnical ''plain'' language appropriate to the target audience (www.plainlanguage.gov)
In summary, there is ample evidence to suggest that social marketing can be an effective tool in health care treatment, to educate both providers and consumers, just as it has been in health promotion and disease prevention. The evidence on social marketing suggests that its underlying principles of behavior change can be used to influence health care provider behavior and consumer decision making through multiple message strategies and channels. Moreover, the health care setting provides a unique opportunity to reinforce messages aimed to consumers through brief counseling of patients by providers (mediated communication of social marketing messages). As a trusted source, providers' reinforcement of social marketing messages adds value beyond the effects of mass communication. Future research should examine the application of social marketing strategies in health care settings, both individually and in combination with other strategies for provider education (e.g., CMEs, publications) and consumer education (e.g., direct-toconsumer marketing) outlined in this article.
